LobbyingGary and Mary West Health Institute lobbying by quarter
Gary and Mary West Health Institute's latest lobbying report covers Q2 2026, at $25K. The four quarters Q4 2025–Q3 2026 total $75K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Gary and Mary West Health Institute
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $75K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $25K | 1 |
| Q1 2023 | $25K | 1 |
| Q2 2023 | $25K | 1 |
| Q3 2023 | $25K | 1 |
| Q4 2023 | $25K | 1 |
| Q1 2024 | $25K | 1 |
| Q2 2024 | $25K | 1 |
| Q3 2024 | $25K | 1 |
| Q4 2024 | $25K | 1 |
| Q1 2025 | $25K | 1 |
| Q2 2025 | $25K | 1 |
| Q3 2025 | $25K | 1 |
| Q4 2025 | $25K | 1 |
| Q1 2026 | $25K | 1 |
| Q2 2026 | $25K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$375K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Waxman Strategies | $375K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| HENRY WAXMAN | US House of Representatives 1975 to 2015 | Q2 2026 |
| JEREMY SHARP | LA,Rep Capps 2001-05 PSM, Sen HELP Comm 2007-10 LD, Sen Dodd 2010 DAS for Leg, HHS, 2011-13 Counselor, HHS, 2013-14 Dep Commissioner for Policy, FDA 2015-17 | Q2 2026 |
| JACKSON RICHARD THEIN | Sen. Jeff Merkley (D-OR), served as Policy Advisor from 2022 - 2023; Legislative Aide from 2021 - 2022; and Legislative Correspondent from 2020 - 2021 | Q1 2026 |
| VAISHNAVI NAGAMMAL JAWAHAR | Vice President/President of the Senate Kamala Harris, served as Domestic Policy Coordinator in 2023 | Q4 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/14for Q2 | Waxman Strategies | $25K |
| 04/20for Q1 | Waxman Strategies | $25K |
| 01/13for Q4 2025 | Waxman Strategies | $25K |
| 25/10/14for Q3 2025 | Waxman Strategies | $25K |
| 25/07/15for Q2 2025 | Waxman Strategies | $25K |
| 25/04/25for Q1 2025 | Waxman Strategies | $25K |
| 25/01/14for Q4 2024 | Waxman Strategies | $25K |
| 24/10/17for Q3 2024 | Waxman Strategies | $25K |
| 24/07/15for Q2 2024 | Waxman Strategies | $25K |
| 24/04/16for Q1 2024 | Waxman Strategies | $25K |
| 24/01/18for Q4 2023 | Waxman Strategies | $25K |
| 23/10/27for Q3 2023 | Waxman Strategies | $25K |
| 23/07/17for Q2 2023 | Waxman Strategies | $25K |
| 23/04/20for Q1 2023 | Waxman Strategies | $25K |
| 23/01/17for Q4 2022 | Waxman Strategies | $25K |